Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockade.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
22 12 2020
Historique:
pubmed: 9 12 2020
medline: 20 2 2021
entrez: 8 12 2020
Statut: ppublish

Résumé

Stroke is a leading cause of death and disability. Recovery depends on a delicate balance between inflammatory responses and immune suppression, tipping the scale between brain protection and susceptibility to infection. Peripheral cholinergic blockade of immune reactions fine-tunes this immune response, but its molecular regulators are unknown. Here, we report a regulatory shift in small RNA types in patient blood sequenced 2 d after ischemic stroke, comprising massive decreases of microRNA levels and concomitant increases of transfer RNA fragments (tRFs) targeting cholinergic transcripts. Electrophoresis-based size-selection followed by qRT-PCR validated the top six up-regulated tRFs in a separate cohort of stroke patients, and independent datasets of small and long RNA sequencing pinpointed immune cell subsets pivotal to these responses, implicating CD14

Identifiants

pubmed: 33288717
pii: 2013542117
doi: 10.1073/pnas.2013542117
pmc: PMC7768686
doi:

Substances chimiques

CD14 protein, human 0
Lipopolysaccharide Receptors 0
Lipopolysaccharides 0
MicroRNAs 0
RNA, Transfer 9014-25-9

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

32606-32616

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Front Mol Neurosci. 2018 Apr 06;11:88
pubmed: 29681794
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Int J Mol Sci. 2013 Jan 22;14(1):2072-84
pubmed: 23340648
Genome Biol. 2014;15(12):550
pubmed: 25516281
Lancet Neurol. 2008 Oct;7(10):915-26
pubmed: 18722812
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1404-9
pubmed: 23297232
PLoS One. 2014 Jun 09;9(6):e99283
pubmed: 24911610
Nat Immunol. 2014 Jun;15(6):503-11
pubmed: 24840981
Nat Methods. 2016 Apr;13(4):366-70
pubmed: 26950747
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
Bioinformatics. 2017 Sep 15;33(18):2941-2942
pubmed: 28541403
Cell. 2015 May 7;161(4):790-802
pubmed: 25957686
Sci Rep. 2017 Feb 21;7:41184
pubmed: 28220888
Stroke. 2015 Nov;46(11):3232-40
pubmed: 26451017
Cell Mol Neurobiol. 2015 Apr;35(3):433-447
pubmed: 25410304
Science. 2011 Oct 7;334(6052):98-101
pubmed: 21921156
RNA Biol. 2010 Sep-Oct;7(5):573-6
pubmed: 20818168
J Clin Invest. 2019 Apr 30;129(7):2946-2951
pubmed: 31039137
Nucleic Acids Res. 2017 Sep 19;45(16):9290-9301
pubmed: 28934507
Nat Rev Neurosci. 2005 Oct;6(10):775-86
pubmed: 16163382
Sci Rep. 2016 Feb 11;6:20850
pubmed: 26865164
BMC Biol. 2014 Oct 01;12:78
pubmed: 25270025
Stroke. 2007 Feb;38(2 Suppl):770-3
pubmed: 17261736
Science. 2020 Jan 31;367(6477):528-537
pubmed: 31831638
J Immunol. 2015 Nov 1;195(9):4446-55
pubmed: 26416280
Cell Rep. 2019 Oct 15;29(3):764-777.e5
pubmed: 31618642
Cell. 2009 Jul 23;138(2):215-9
pubmed: 19632169
J Cereb Blood Flow Metab. 2009 May;29(5):994-1002
pubmed: 19293821
J Biol Chem. 2005 Nov 18;280(46):38247-58
pubmed: 16169848
Nature. 2017 Dec 7;552(7683):57-62
pubmed: 29186115
Immunity. 2009 Dec 18;31(6):965-73
pubmed: 20005135
Cancer Res. 2017 Jun 15;77(12):3194-3206
pubmed: 28446464
Cell Rep. 2018 Dec 18;25(12):3356-3370.e4
pubmed: 30566862
Cell Rep. 2018 Oct 30;25(5):1346-1358
pubmed: 30380423
Nat Med. 2017 Jun;23(6):723-732
pubmed: 28394332
Front Aging Neurosci. 2016 Feb 22;8:29
pubmed: 26941641
BMC Genomics. 2014 Jun 14;15:474
pubmed: 24928098
Neurology. 2011 Oct 4;77(14):1338-45
pubmed: 21940613
Mol Med. 2010 Jul-Aug;16(7-8):278-86
pubmed: 20464061
BMC Bioinformatics. 2009 Oct 12;10:328
pubmed: 19821977
Trends Immunol. 2018 Feb;39(2):123-134
pubmed: 29236673
Cell. 1994 Mar 11;76(5):821-8
pubmed: 7510216
Front Immunol. 2018 May 22;9:1108
pubmed: 29872438
Mol Med. 2016 Sep;22:156-161
pubmed: 27257683
Front Immunol. 2017 Sep 06;8:1085
pubmed: 28932225
J Cereb Blood Flow Metab. 2020 Apr;40(4):775-786
pubmed: 30966854
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8451-8456
pubmed: 30962382
Brain. 2019 Apr 1;142(4):978-991
pubmed: 30860258
Front Immunol. 2018 Nov 05;9:2522
pubmed: 30455690
J Neurosci. 2016 Apr 13;36(15):4182-95
pubmed: 27076418
J Cereb Blood Flow Metab. 2017 Dec;37(12):3671-3682
pubmed: 27733675
Trends Neurosci. 2015 Jul;38(7):448-58
pubmed: 26100140
Eur Neurol. 2007;58(4):224-7
pubmed: 17823536
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
J Cell Biol. 2009 Apr 6;185(1):35-42
pubmed: 19332886
EMBO J. 2007 Sep 19;26(18):4138-48
pubmed: 17762869
Bio Protoc. 2014 Jul 20;4(14):
pubmed: 27570796
Nature. 2000 May 25;405(6785):458-62
pubmed: 10839541
Elife. 2015 Aug 12;4:
pubmed: 26267216

Auteurs

Katarzyna Winek (K)

The Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.
The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.

Sebastian Lobentanzer (S)

Department of Pharmacology, College of Pharmacy, Goethe University, 60438 Frankfurt am Main, Germany.

Bettina Nadorp (B)

The Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.
The Grass Center for Bioengineering, Benin School of Computer Science and Engineering, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.

Serafima Dubnov (S)

The Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.
The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.

Claudia Dames (C)

The Institute for Medical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Sandra Jagdmann (S)

The Institute for Medical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Gilli Moshitzky (G)

The Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.
The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.

Benjamin Hotter (B)

NeuroCure Clinical Research, Center for Stroke Research Berlin, Department of Neurology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Christian Meisel (C)

The Institute for Medical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

David S Greenberg (DS)

The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.

Sagiv Shifman (S)

Department of Genetics, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.

Jochen Klein (J)

Department of Pharmacology, College of Pharmacy, Goethe University, 60438 Frankfurt am Main, Germany.

Shani Shenhar-Tsarfaty (S)

Department of Internal Medicine "C," "D," and "E," Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, 6997801 Tel Aviv, Israel.

Andreas Meisel (A)

NeuroCure Clinical Research, Center for Stroke Research Berlin, Department of Neurology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Hermona Soreq (H)

The Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel; hermona.soreq@mail.huji.ac.il.
The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH